Characterization and Management of Adverse Reactions From the CLEAR Study in Advanced Renal Cell Carcinoma Treated With Lenvatinib Plus Pembrolizumab
- Motzer, R.
- George, S.
- Merchan, J.R.
- Hutson, T.E.
- Song, X.
- Perini, R.F.
- Xie, R.
- Bapat, U.
- Puente, J.
ISSN: 1549-490X, 1083-7159
Datum der Publikation: 2023
Ausgabe: 28
Nummer: 6
Seiten: 501-509
Art: Artikel